0001567619-21-005947.txt : 20210310 0001567619-21-005947.hdr.sgml : 20210310 20210309214202 ACCESSION NUMBER: 0001567619-21-005947 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210309 EFFECTIVENESS DATE: 20210310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN MEDICAL INC CENTRAL INDEX KEY: 0000840551 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-391584 FILM NUMBER: 21728065 BUSINESS ADDRESS: STREET 1: 155 UNIVERSITY AVENUE, SUITE 750 CITY: TORONTO STATE: A6 ZIP: M5H 3B7 BUSINESS PHONE: 416-548-7522 X153 MAIL ADDRESS: STREET 1: 155 UNIVERSITY AVENUE, SUITE 750 CITY: TORONTO STATE: A6 ZIP: M5H 3B7 D/A 1 primary_doc.xml X0708 D/A LIVE 0000840551 TITAN MEDICAL INC 155 UNIVERSITY AVENUE SUITE 750 TORONTO A6 ONTARIO, CANADA M5H 3B7 416-548-7522 ONTARIO, CANADA None None Corporation true David McNally 155 University Avenue Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Executive Officer Director Monique L. Delorme 155 University Avenue, Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Executive Officer Paul Cataford 155 University Avenue, Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Director Anthony J. Giovinazzo 155 University Avenue, Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Director Cary G. Vance 155 University Avenue, Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Director Stephen Randall 155 University Avenue, Suite 750 Toronto A6 ONTARIO, CANADA M5H 3B7 Director Other Decline to Disclose 06b true 0001157523-21-000306 2021-02-24 true true true true true Unit offering; each Unit consists of one common share and one-half of one common share purchase warrant; each whole warrant exercisable at $3.00 for 24 months. false 0 Bloom Burton Securities Inc. None Haywood Securities (USA) Inc. 42072 200 Burrard Street Suite 700 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3L6 CA CALIFORNIA IL ILLINOIS TX TEXAS false 4941300 3040800 1900500 Total remaining to be sold represents maximum potential exercise price of warrants. false 4 212856 true 0 In addition to the cash compensation above, the agents received 88,690 warrants in connection with certain U.S. sales; each warrant is exercisable for one share of common stock at $3.00 for 24 months. 0 false TITAN MEDICAL INC /s/ Monique L. Delorme Monique L. Delorme Chief Financial Officer 2021-03-09